Latest Commercialization News

Optiscan Imaging Ltd has launched its first in-human breast cancer study and unveiled a new veterinary imaging device, while securing a key US collaboration to support FDA submissions.

Clean TeQ Water Limited reported solid progress across multiple key projects and improved cash receipts in its Q4 FY25 update, underscoring its growing foothold in advanced water treatment and resource recovery.

NoviqTech Limited has expanded its sustainability technology footprint through key partnerships in hydrogen and battery recycling, secured a significant grant extension, and announced a $1.25 million capital raise to fuel growth.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

State Gas Limited has successfully drilled two new wells at its Rolleston West Project, intersecting significant coal seams and initiating production testing, while engaging NSAI for independent reserve certification.

Viridis Mining and Minerals has been selected for up to US$903 million in Brazilian government funding to advance its Colossus Rare Earth Project, while delivering Brazil’s first locally sourced rare earth oxides and posting robust Pre-Feasibility Study results.

Theta Gold Mines secures a pivotal US$35 million loan facility and board approval to mine, marking significant progress in the development of its TGME Gold Mine Project in South Africa.

SportsHero Limited has advanced its iGV Family Game Pass commercialization with launches in Indonesia and the Philippines, backed by new Telco partnerships and a A$1.65 million capital raise.

International Graphite Limited (ASX, IG6) has signed a cooperation agreement to develop a 3,000 t/y expandable graphite facility in Germany, advancing its global footprint alongside progress at its Collie micronising plant and Springdale project, supported by potential US Department of Defense funding.

Weebit Nano reports solid progress in Q4 FY25 with key technology milestones and its first product design license, backed by a strong cash position.

Skin Elements Limited advances its proprietary SE Formula biotechnology with ECO-Nurture poised for commercial rollout in 2026, alongside progress in disinfectant and sunscreen product lines.

Hexima Limited reported a stable cash balance of AUD 1.54 million for Q2 2025, with only minor net cash used in operating activities. The company remains focused on strategic opportunities to enhance shareholder value.